Приказ основних података о документу

dc.creatorNabergoj Makovec, Urska
dc.creatorGoetzinger, Catherine
dc.creatorRibaut, Janette
dc.creatorBarnestein-Fonseca, Pilar
dc.creatorHaupenthal, Frederik
dc.creatorHerdeiro, Maria
dc.creatorGrant, Sean Patrick
dc.creatorJácome, Cristina
dc.creatorRoque, Fatima
dc.creatorSmits, Dins
dc.creatorTadić, Ivana
dc.creatorDima, Alexandra
dc.date.accessioned2022-05-13T09:34:54Z
dc.date.available2022-05-13T09:34:54Z
dc.date.issued2022
dc.identifier.issn2044-6055
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/4098
dc.description.abstractIntroduction An online interactive repository of available medication adherence technologies may facilitate their selection and adoption by different stakeholders. Developing a repository is among the main objectives of the European Network to Advance Best practices and technoLogy on medication adherencE (ENABLE) COST Action (CA19132). However, meeting the needs of diverse stakeholders requires careful consideration of the repository structure. Methods and analysis A real-time online Delphi study by stakeholders from 39 countries with research, practice, policy, patient representation and technology development backgrounds will be conducted. Eleven ENABLE members from 9 European countries formed an interdisciplinary steering committee to develop the repository structure, prepare study protocol and perform it. Definitions of medication adherence technologies and their attributes were developed iteratively through literature review, discussions within the steering committee and ENABLE Action members, following ontology development recommendations. Three domains (product and provider information (D1), medication adherence descriptors (D2) and evaluation and implementation (D3)) branching in 13 attribute groups are proposed: product and provider information, target use scenarios, target health conditions, medication regimen, medication adherence management components, monitoring/measurement methods and targets, intervention modes of delivery, target behaviour determinants, behaviour change techniques, intervention providers, intervention settings, quality indicators and implementation indicators. Stakeholders will evaluate the proposed definition and attributes’ relevance, clarity and completeness and have multiple opportunities to reconsider their evaluations based on aggregated feedback in real-time. Data collection will stop when the predetermined response rate will be achieved. We will quantify agreement and perform analyses of process indicators on the whole sample and per stakeholder group. Ethics and dissemination Ethical approval for the COST ENABLE activities was granted by the Malaga Regional Research Ethics Committee. The Delphi protocol was considered compliant regarding data protection and security by the Data Protection Officer from University of Basel. Findings from the Delphi study will form the basis for the ENABLE repository structure and related activities.
dc.publisherBMJ Publishing Group
dc.relationThis work was supported by COST Action ENABLE—European Network to Advance Best practices & technoLogy on medication adherencE’, number CA19132
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//
dc.relationIDEXLYON grant (16-IDEX-0005; 2018-2021)
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.sourceBMJ open
dc.subjecthealth informatics
dc.subjectpublic health
dc.subjectsocial medicine
dc.titleDeveloping a medication adherence technologies repository: proposed structure and protocol for an online real-time Delphi study
dc.typearticle
dc.rights.licenseBY-NC
dc.citation.volume12
dc.citation.issue4
dc.citation.rankM22
dc.identifier.wos000787543100007
dc.identifier.doi10.1136/bmjopen-2021-059674
dc.identifier.scopus2-s2.0-85128802668
dc.identifier.fulltexthttp://farfar.pharmacy.bg.ac.rs/bitstream/id/9651/Developing_a_medicationl_pub_2022.pdf
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу